TIAA CREF Investment Management’s Pulse Biosciences PLSE Stock Holding History

TIAA CREF Investment Management’s Portfolio PLSE Stock Details PLSE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	$342K	Sell	19,417 -197	-1%	-$3.09K	﹤0.01%	2741
2018 Q4	$225K	Hold	19,614	–	–	﹤0.01%	2852
2018 Q3	$278K	Sell	19,614 -1,345	-6%	-$19.1K	﹤0.01%	2907
2018 Q2	$317K	Sell	20,959 -603	-3%	-$10.2K	﹤0.01%	2933
2018 Q1	$292K	Hold	21,562	–	–	﹤0.01%	2908
2017 Q4	$509K	Sell	21,562 -3,140	-13%	-$74.1K	﹤0.01%	2762
2017 Q3	$460K	Hold	24,702	–	–	﹤0.01%	2861
2017 Q2	$853K	Buy	+24,702	New	+$679K	﹤0.01%	2621

Other funds holding PLSE

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

GAM

Griffin Asset Management New York $887M AUM 21.42% 1-Year Est. Return

TIAA FSB Jacksonville, Florida $27.6B AUM 14.26% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

TIAA CREF Investment Management's PLSE Position: Q1 2019 in Review

TIAA CREF Investment Management reduced its Pulse Biosciences (PLSE) stake by 1% in Q1 2019, selling an estimated $3.09K and leaving 19,417 shares worth $342K. The position accounts for ﹤0.01% of the portfolio, ranked #2741.

TIAA CREF Investment Management first reported a position in PLSE in Q2 2017 and has held it in 8 quarters since. The position peaked at $853K in Q2 2017. 41 funds tracked by Wall St. Rank hold PLSE as of Q1 2019.

TIAA CREF Investment Management held 19,417 shares of Pulse Biosciences worth $342K as of Q1 2019.
TIAA CREF Investment Management sold 197 Pulse Biosciences shares in Q1 2019, an estimated $3.09K.
Pulse Biosciences made up ﹤0.01% of TIAA CREF Investment Management's portfolio in Q1 2019, its #2741 holding.
TIAA CREF Investment Management first reported a position in Pulse Biosciences in Q2 2017 and has held it in 8 quarters since.
TIAA CREF Investment Management's Pulse Biosciences position peaked at $853K in Q2 2017.
41 funds tracked by Wall St. Rank held Pulse Biosciences as of Q1 2019.

Based on TIAA CREF Investment Management's 13F filing for Q1 2019, filed 14 May 2019.